Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by E Kovats
Combined Intravenous and Intraperitoneal Chemotherapy With Fluorouracil + Leucovorin vs Fluorouracil + Levamisole for Adjuvant Therapy of Resected Colon Carcinoma
British Journal of Cancer
Cancer Research
Oncology
Related publications
Comparison of Adverse Events During 5-Fluorouracil Versus 5-Fluorouracil/Oxaliplatin Adjuvant Chemotherapy for Stage III Colon Cancer
Cancer
Cancer Research
Oncology
Synergistic Effect of Triptolide Combined With 5-Fluorouracil on Colon Carcinoma
Postgraduate Medical Journal
Medicine
Effect of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Cetuximab on Survival Among Patients With Resected Stage III Colon Cancer
JAMA - Journal of the American Medical Association
Medicine
Adjuvant Bidirectional Chemotherapy With Intraperitoneal Pemetrexed Combined With Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma
Gastroenterology Research and Practice
Hepatology
Gastroenterology
Neoadjuvant, Adjuvant and Long-Term Intravenous/Intraperitoneal Chemotherapy, Hyperthermic Intraperitoneal Chemotherapy, Early Postoperative Intraperitoneal Chemotherapy for Ovarian Cancer
Journal of Peritoneum (and other serosal surfaces)
Serum Iron Levels as a New Biomarker in Chemotherapy With Leucovorin and Fluorouracil Plus Oxaliplatin or Leucovorin and Fluorouracil Plus Irinotecan, With or Without Molecularly-Targeted Drugs
Molecular and Clinical Oncology
Cancer Research
Oncology
Long-Term Neurotoxicity Effects of Oxaliplatin Added to Fluorouracil and Leucovorin as Adjuvant Therapy for Colon Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Trials C-07 and LTS-01
Cancer
Cancer Research
Oncology
GOLPH3 Predicts Survival of Colorectal Cancer Patients Treated With 5-Fluorouracil-Based Adjuvant Chemotherapy
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Epirubicin and Cyclophosphamide, Methotrexate, and Fluorouracil as Adjuvant Therapy for Early Breast Cancer
New England Journal of Medicine
Medicine